2016 American Transplant Congress
Renal Efficiency: A New Metric for Evaluating Kidneys in Living Donors.
The Ohio State University, Columbus, OH.
Donor age, quality of the graft, and the size/weight of the donated kidney are factors that may affect subsequent transplant outcomes. Morphological renal measurements may…2016 American Transplant Congress
Comparison of Renal Outcomes Between ABO-Incompatible and Kidney Paired Donation Transplantation In Living Donors.
Kidney Transplant Unit, UCSF, San Francisco, CA.
Introduction: ABO incompatible transplantation (ABOi Tx) broadens the donor pool and decreases wait times for patients who don't have a blood type compatible living kidney…2016 American Transplant Congress
Urinary Neutrophil Gelatinase-Associated Lipocalin in Living Kidney Donor Nephrectomy.
Introduction: Urinary neutrophil gelatinase-associated lipocalin (uNGAL) is a marker for acute kidney injury. This study was conducted to evaluate the efficacy of perioperative uNGAL in…2016 American Transplant Congress
Is Ketorolac Really Safe for Donor Nephrectomy?
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI.
Background. Ketorolac is a nonsteroidal anti-inflammatory drug used for postoperative pain management. The purpose of this study is to assess the impact of ketorolac after…2016 American Transplant Congress
Comparison of Surgical Correction Techniques for Post-Kidney Transplantation Vesicoureteral Reflux.
PURPOSEThe aim of this study was to compare extravesical seromuscular tunnel lengthening technique with uretero-ureteral/pyelo-ureteral anastomosis techniques in post-transplant vesicoureteral reflux (VUR) management.MATERIALS AND METHODSWe…2016 American Transplant Congress
Incidence, Risk Factors, and Outcomes of Delayed Graft Function in Deceased Donor Kidney Transplantation in a Brazilian Center.
Background. A high incidence of delayed graft function (DGF), after deceased donor kidney transplantation, occurs in Brazil and the reasons for such finding have not…2016 American Transplant Congress
Outcomes in Black vs Non-Black Patients Administered Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT.
Studies consistently show worse outcomes for black vs non-black kidney transplant recipients. At 7 yrs post-transplant in BENEFIT, bela was associated with superior graft survival…2016 American Transplant Congress
Chemoprevention of Cutaneous Squamous Cell Carcinoma in Renal Transplant Recipients: A Case-Controlled Analysis.
Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
Organ transplant recipients are up to 200 times more likely to develop cutaneous squamous cell carcinoma (SCC) than age-matched general populations. Systemic retinoids, such as…2016 American Transplant Congress
Impact of BKV Subtype Distribution on BKV Nephropathy, Viremia, and Renal Outcome in Patients After Renal Transplantation.
Factors determining the course of BK viral (BKV) infection remain uncertain. We studied the role of BKV subtype distribution in BKV-infected patients after renal transplantation.-We…2016 American Transplant Congress
Long Term Safety of Intravenous Ketorolac Use After Donor Nephrectomy.
Background: The benefit and short-term safety have been established in previous studies; however, the risk of bleeding and long-term renal impairment in patients undergoing donor…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 27
- Next Page »